A longitudinal brain fMRI study of chemotherapy-induced peripheral neuropathy in 50 breast cancer patients.
Ian R. Kleckner(University of Maryland, College Park), Shelli R. Kesler(Livestrong Foundation), Richard Ν. Aslin(Yale University), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Vikram Rao(The University of Texas MD Anderson Cancer Center), Matthew Asare(Baylor University), Michelle C. Janelsins(University of Rochester), Calvin L. Cole(University of Rochester Medicine), Nimish Mohile(University of Rochester Medical Center), Po‐Ju Lin(University of Rochester Medicine)
Cited by 3
Related Papers
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program
|Journal of Clinical Oncology|2009|564
Applied Discriminant Analysis
|Technometrics|1995|409
Cognitive Complaints in Survivors of Breast Cancer After Chemotherapy Compared With Age-Matched Controls: An Analysis From a Nationwide, Multicenter, Prospective Longitudinal Study
|Journal of Clinical Oncology|2017|395
Statistical phonetic learning in infants: facilitation and feature generalization
|Developmental Science|2007|375